SCHEMBL680199

SCHEMBL680199

C=C(C(C)C)[C@H](CNC1CCC(C)(C)CC1)c1ccc(Cl)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKT3 Q9Y243 7/20 0.36
AKT2 P31751 6/20 0.36
AKT1 P31749 5/20 0.36
CYP3A4 P08684 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MITF O75030 1/20 0.36
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD11B1 P28845 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
P2RX7 Q99572 1/20 0.33
POLB P06746 1/20 0.33
MCHR1 Q99705 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL681566 0.90 MEN1 (0.40) AKT3AKT2AKT1CYP3A4MEN1
SCHEMBL680817 0.88 AKT3 (0.39) AKT3AKT2AKT1CYP3A4MEN1
SCHEMBL681791 0.88 POLB (0.35) HSD11B1POLB
SCHEMBL681038 0.86 AKT3 (0.35) AKT3AKT2AKT1CYP3A4GAA
SCHEMBL680141 0.86 AKT3 (0.45) AKT3AKT2AKT1GAAHPGD
SCHEMBL684211 0.85 BRD4 (0.41) AKT3AKT2AKT1CYP3A4MEN1
SCHEMBL680114 0.85 BRD4 (0.42) AKT3AKT2AKT1CYP3A4MEN1
SCHEMBL681300 0.84 AKT3 (0.47) AKT3AKT2AKT1CYP3A4MEN1
SCHEMBL2739258 0.84 AKT3 (0.38) AKT3AKT2AKT1CYP3A4MEN1
SCHEMBL17803803 0.82 AKT1 (0.48) AKT3AKT2AKT1CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359340-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2016-06-07 US disclosed
US-8063050-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2011-11-22 US disclosed